Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

Laurent Younes, Marilyn Albert, Michael I. Miller

Research output: Contribution to journalArticle

Abstract

This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8-10 years prior to onset, followed by the hippocampus, 2-4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease.

Original languageEnglish (US)
Pages (from-to)178-187
Number of pages10
JournalNeuroImage: Clinical
Volume5
DOIs
StatePublished - 2014

Fingerprint

Entorhinal Cortex
Temporal Lobe
Alzheimer Disease
Amygdala
Atrophy
Hippocampus
Brain
Magnetic Resonance Imaging

Keywords

  • Abbreviations
  • AD
  • Alzheimer's disease
  • CDR
  • Clinical Center of the National Institutes of Health
  • clinical dementia rating
  • diffeomorphometry
  • entorhinal cortex
  • ERC
  • family-wise error rate
  • FWER
  • Geriatric Psychiatry Branch
  • GPB
  • MCI
  • mild cognitive impairment
  • mini-mental state exam
  • MMSE
  • National Institute for Mental Health
  • National Institute on Aging
  • NIA
  • NIH
  • NIMH
  • region-of-interest large deformation diffeomorphic metric mapping
  • residual sum of squares
  • ROI-LDDMM
  • RSS
  • SPGR
  • spoiled gradient echo
  • study of shape using a metric on the diffeomorphic connections between structures

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Cognitive Neuroscience
  • Neurology

Cite this

Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. / Younes, Laurent; Albert, Marilyn; Miller, Michael I.

In: NeuroImage: Clinical, Vol. 5, 2014, p. 178-187.

Research output: Contribution to journalArticle

@article{22e129c86d6e4c218b6e81e9322ec475,
title = "Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease",
abstract = "This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8-10 years prior to onset, followed by the hippocampus, 2-4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4{\%} (left side) and 1.6{\%} (right side) annually. The same changepoint model for ERC volume gives 3.0{\%} and 2.7{\%} on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease.",
keywords = "Abbreviations, AD, Alzheimer's disease, CDR, Clinical Center of the National Institutes of Health, clinical dementia rating, diffeomorphometry, entorhinal cortex, ERC, family-wise error rate, FWER, Geriatric Psychiatry Branch, GPB, MCI, mild cognitive impairment, mini-mental state exam, MMSE, National Institute for Mental Health, National Institute on Aging, NIA, NIH, NIMH, region-of-interest large deformation diffeomorphic metric mapping, residual sum of squares, ROI-LDDMM, RSS, SPGR, spoiled gradient echo, study of shape using a metric on the diffeomorphic connections between structures",
author = "Laurent Younes and Marilyn Albert and Miller, {Michael I.}",
year = "2014",
doi = "10.1016/j.nicl.2014.04.009",
language = "English (US)",
volume = "5",
pages = "178--187",
journal = "NeuroImage: Clinical",
issn = "2213-1582",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

AU - Younes, Laurent

AU - Albert, Marilyn

AU - Miller, Michael I.

PY - 2014

Y1 - 2014

N2 - This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8-10 years prior to onset, followed by the hippocampus, 2-4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease.

AB - This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8-10 years prior to onset, followed by the hippocampus, 2-4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease.

KW - Abbreviations

KW - AD

KW - Alzheimer's disease

KW - CDR

KW - Clinical Center of the National Institutes of Health

KW - clinical dementia rating

KW - diffeomorphometry

KW - entorhinal cortex

KW - ERC

KW - family-wise error rate

KW - FWER

KW - Geriatric Psychiatry Branch

KW - GPB

KW - MCI

KW - mild cognitive impairment

KW - mini-mental state exam

KW - MMSE

KW - National Institute for Mental Health

KW - National Institute on Aging

KW - NIA

KW - NIH

KW - NIMH

KW - region-of-interest large deformation diffeomorphic metric mapping

KW - residual sum of squares

KW - ROI-LDDMM

KW - RSS

KW - SPGR

KW - spoiled gradient echo

KW - study of shape using a metric on the diffeomorphic connections between structures

UR - http://www.scopus.com/inward/record.url?scp=84904874330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904874330&partnerID=8YFLogxK

U2 - 10.1016/j.nicl.2014.04.009

DO - 10.1016/j.nicl.2014.04.009

M3 - Article

VL - 5

SP - 178

EP - 187

JO - NeuroImage: Clinical

JF - NeuroImage: Clinical

SN - 2213-1582

ER -